Hinge Health Inc Dossier - Source-backed chat

Hinge Health Inc

HNGENYSE

SectorHealth Care

IndustryHealth Information Services

Beta (adjusted)1.23

Intrinsic Value $94.23median of 4 methods · middle span $84-$105based on filings through 31 Mar 2026

Market Price $97.94Price as of 1 Oct 2026

Near fair valueIntrinsic value is 4% below the market price

−50% · IV below pricenear fair value ±15%IV above price · +50%

Data confidence Sign in to view data confidence

Market Cap $7.9B

Shares Outstanding 77.4M diluted

Next Earnings Date3 Nov 2026

All prices and values are periodic snapshots, not live quotes. Source dates are shown for reference.

Thesis

Street consensus, scenarios, merits, risks, and invalidation triggers

AI-assisted

Thesis Summary

Hinge Health is a clear leader in the virtual musculoskeletal (MSK) care market, demonstrating robust top-line growth and a significant inflection toward profitability. By leveraging an AI-powered care model, wearable devices, and expert clinicians, the company has successfully automated approximately 95% of traditional physical therapy human care hours. This high degree of automation drives exceptional gross margins (85% in Q1 2026) and supports a rapid expansion of operating margins. With raised full-year 2026 revenue guidance of $818M to $824M (representing 40% YoY growth at the midpoint) and an expected non-GAAP operating margin of 27%, Hinge Health represents a highly scalable, high-margin digital health platform with a strong balance sheet and a clear path to sustained GAAP profitability.

This section is the 12-month view: analyst targets and the probability-weighted scenarios built from them. The intrinsic value at the top of this page answers a different question: what the business is worth today.

Street view · analyst 12-month targets15 analysts · as of 18 Aug 2026

Low · most bearish analyst$85.00

Mean target$106.47

High · most bullish analyst$140.00

Street targets sit above today's price; our intrinsic value sits below it. Different horizons, different questions.

Our research · scenarios, merits, risks, and invalidation triggersResearch as of 18 Sep 2026

Scenarios · 12-month scenario targetsAnchored at research date

Bear CaseDownside scenario

$85.00

Increased competition from direct competitors like Sword Health pressures pricing models, leading to flat or declining yields per member. Slower-than-expected adoption of new clinical programs (e.g., Migraine Care) limits expansion, causing FY2026 revenue to come in at the lower end of guidance (~$798 million) and compressing non-GAAP operating margins to 20-22%.

Base CaseCentral scenario

$106.47

Matches the consensus mean

Hinge Health delivers on its raised FY2026 guidance, achieving revenue between $818 million and $824 million (40% YoY growth) and non-GAAP operating margins of approximately 27%. Client retention remains near 98% with net dollar retention above 110%, supported by clinically validated outcomes and a proven 3.0x ROI for employers.

Bull CaseUpside scenario

$140.00

Accelerated adoption of HingeSelect (including orthopedic surgery integration) and the newly launched Migraine Care Program drives higher member conversion and yields. Enterprise client expansion continues to penetrate the Fortune 500, pushing full-year 2026 revenue above $830 million and expanding non-GAAP operating margins beyond 30% due to the high scalability of the AI-driven care model.

Scenarios are anchored to street consensus at the research date, with our probabilities and rationale.

Key Investment Merits

Highly scalable, software-led business model with 85% gross margins driven by AI-enabled care automation.
Clinically validated outcomes demonstrating a 3.0x ROI ($2,941 annual savings per member) which secures high client retention (98%).

Key Investment Risks

Intense competition in the digital MSK space, particularly from well-funded players like Sword Health.
Client concentration and reliance on annual benefit enrollment cycles of self-insured employers.
Execution risks associated with expanding into new clinical areas (e.g., Migraine Care) and integrating physical networks (HingeSelect).

Thesis Invalidation Triggers

A significant drop in net dollar retention below 100%, indicating client churn or reduced member engagement.
Failure to achieve non-GAAP operating profitability or a reversal in operating margin expansion.
Regulatory changes or legal challenges affecting digital health delivery models or clinical efficacy claims.

All scenarios are estimates and subject to change. Past performance is not indicative of future results.

Quality Pillars Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Explore this dossier

ValuationIntrinsic value, the six-method breakdown, peer medians, and your assumptions sandbox.Financial SnapshotRevenue, profitability, returns, balance sheet, dividends, and the filing-level detail.Qualitative AnalysisBusiness overview, strategic initiatives, and mergers, acquisitions & partnerships.Outlook & Key DatesForward estimates, reporting calendar, and the monitoring framework.